Structures by: Smolenski V. A.
Total: 27
RS-AR-9
C68H56Br2Cu2N6P2S2
Dalton transactions (Cambridge, England : 2003) (2020) 49, 47 17350-17367
a=10.6202(6)Å b=11.2960(5)Å c=13.7122(7)Å
α=72.604(4)° β=70.354(5)° γ=75.461(4)°
C70H60Ag2Cl2N6P2S2
C70H60Ag2Cl2N6P2S2
Dalton transactions (Cambridge, England : 2003) (2020) 49, 47 17350-17367
a=10.4921(7)Å b=12.0020(6)Å c=13.8200(10)Å
α=82.287(5)° β=79.882(6)° γ=75.133(5)°
RS-AR-12
C68H56Ag2Br2N6P2S2
Dalton transactions (Cambridge, England : 2003) (2020) 49, 47 17350-17367
a=10.7478(4)Å b=11.3867(4)Å c=13.6861(7)Å
α=72.548(4)° β=72.022(4)° γ=75.693(3)°
C53H45CuN3P2S2
C53H45CuN3P2S2
Dalton transactions (Cambridge, England : 2003) (2020) 49, 47 17350-17367
a=9.3567(3)Å b=13.0349(4)Å c=19.9282(7)Å
α=87.801(3)° β=83.782(3)° γ=84.846(2)°
C12H24ClCuN4S2
C12H24ClCuN4S2
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=14.0097(4)Å b=14.0814(3)Å c=18.9263(6)Å
α=90° β=108.984(3)° γ=90°
C42H79.76Cl6Cu6N12S6
C42H79.76Cl6Cu6N12S6
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=17.5632(7)Å b=17.5632(7)Å c=17.7092(9)Å
α=90° β=90° γ=120°
C54H60Cu4I4N12S6
C54H60Cu4I4N12S6
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=9.573(4)Å b=10.198(5)Å c=16.821(8)Å
α=100.18(2)° β=99.48(3)° γ=98.79(3)°
C10H20CuIN4S2
C10H20CuIN4S2
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=8.6359(7)Å b=7.3154(5)Å c=26.7530(18)Å
α=90.00° β=95.591(3)° γ=90.00°
C18H20ClCuN4S2
C18H20ClCuN4S2
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=13.5161(5)Å b=10.4367(5)Å c=28.1083(14)Å
α=90° β=92.378(5)° γ=90°
C8H16ClCuN4S2
C8H16ClCuN4S2
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=12.9744(16)Å b=7.6298(10)Å c=14.1661(16)Å
α=90° β=105.936(13)° γ=90°
C20H36Cu5I6N8S2
C20H36Cu5I6N8S2
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=8.0690(4)Å b=9.9078(6)Å c=13.1167(8)Å
α=99.126(5)° β=102.165(5)° γ=111.425(5)°
C36H40Br2Cu2N8S4
C36H40Br2Cu2N8S4
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=15.6581(17)Å b=12.6438(15)Å c=19.708(2)Å
α=90.00° β=94.694(4)° γ=90.00°
C9H10CuIN2S
C9H10CuIN2S
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=15.6938(9)Å b=12.7042(6)Å c=11.1498(6)Å
α=90° β=95.604(5)° γ=90°
C8H16BrCuN4S2
C8H16BrCuN4S2
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=13.2573(9)Å b=7.4836(5)Å c=14.3879(10)Å
α=90° β=107.330(7)° γ=90°
C8H16CuIN4S2
C8H16CuIN4S2
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=13.710(3)Å b=7.422(4)Å c=14.723(2)Å
α=90.00° β=109.448(5)° γ=90.00°
JPL-212
C14H28BrCuN4S2
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=7.3515(4)Å b=10.0895(5)Å c=14.3386(6)Å
α=102.109(4)° β=101.930(4)° γ=100.673(4)°
1-(2-Hydroxy-5-methoxyphenyl)ethanone 4,4-dimethylthiosemicarbazone
C12H17N3O2S
Acta Crystallographica Section E (2015) 71, 11 o811-o812
a=15.7097(12)Å b=7.8300(5)Å c=21.2351(19)Å
α=90° β=92.635(8)° γ=90°
2-[(2-(Hydroxyimino)-1-phenylpropylidene]-<i>N</i>-phenyl]hydrazinecarbothioamide
C16H16N4OS
Acta Crystallographica Section E (2015) 71, 10 o796-o797
a=5.4955(6)Å b=27.973(2)Å c=10.4175(9)Å
α=90° β=92.444(9)° γ=90°
(2<i>E</i>)-1-(5-Chlorothiophen-2-yl)-3-(4-ethylphenyl)prop-2-en-1-one
C15H13ClOS
Acta Crystallographica Section E (2015) 71, 9 1093-1099
a=6.0154(5)Å b=8.6358(5)Å c=14.0548(9)Å
α=74.428(5)° β=88.225(6)° γ=70.417(6)°
(2E)-1-(5-Bromothiophen-2-yl)-3-(4-ethylphenyl)prop-2-en-1-one
C15H13BrOS
Acta Crystallographica Section E (2015) 71, 9 1093-1099
a=5.9745(6)Å b=8.6636(7)Å c=14.3039(12)Å
α=74.731(7)° β=88.146(7)° γ=70.334(8)°
(2<i>E</i>)-1-(5-Chlorothiophen-2-yl)-3-(4-ethoxyphenyl)prop-2-en-1-one
C15H13ClO2S
Acta Crystallographica Section E (2015) 71, 9 1093-1099
a=16.3577(6)Å b=7.4518(4)Å c=11.0892(4)Å
α=90° β=92.260(3)° γ=90°
(2<i>E</i>)-1-(5-Bromothiophen-2-yl)-3-(4-ethoxyphenyl)prop-2-en-1-one
C15H13BrO2S
Acta Crystallographica Section E (2015) 71, 9 1093-1099
a=16.5498(7)Å b=7.5069(4)Å c=11.1574(5)Å
α=90° β=92.618(4)° γ=90°
(2<i>E</i>)-1-(5-Chlorothiophen-2-yl)-3-(4-bromophenyl)prop-2-en-1-one
C13H8BrClOS
Acta Crystallographica Section E (2015) 71, 9 1093-1099
a=6.0152(8)Å b=8.5691(12)Å c=13.1824(9)Å
α=75.250(10)° β=81.446(8)° γ=70.281(12)°
(2<i>E</i>)-1-(5-Bromothiophen-2-yl)-3-(3-methoxyphenyl)prop-2-en-1-one
C14H11BrO2S
Acta Crystallographica Section E (2015) 71, 9 1093-1099
a=9.2726(6)Å b=11.3948(8)Å c=12.1472(7)Å
α=90° β=93.273(6)° γ=90°
Ethyl 2-phenyl-4-(prop-2-yn-1-yloxy)-5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-<i>d</i>]pyrimidine-7-carboxylate
C21H19N3O3S
Acta crystallographica. Section E, Crystallographic communications (2015) 71, Pt 11 o836-7
a=13.143(2)Å b=8.013(2)Å c=17.880(2)Å
α=90° β=96.129(14)° γ=90°
Methyl (2<i>Z</i>)-2-[(2<i>Z</i>)-2-(2-cyclopentylidenehydrazin-1-ylidene)-4-oxo-3-phenyl-1,3-thiazolidin-5-ylidene]ethanoate
C17H17N3O3S
Acta crystallographica. Section E, Crystallographic communications (2015) 71, Pt 10 o776-7
a=5.5215(3)Å b=16.1299(8)Å c=18.7112(9)Å
α=90° β=93.980(5)° γ=90°
C14H28CuIN4S2
C14H28CuIN4S2
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1324-1339
a=7.4901(4)Å b=10.3906(4)Å c=14.1896(8)Å
α=102.429(4)° β=100.467(5)° γ=100.840(4)°